%%PAGEMETA_floodlighttags%%

OraQuick HIV Grant

The OraQuick HIV Testing Grant is a partnership between OraSure and The AIDS Institute to encourage the development of innovative HIV self-testing programs. We invite you to learn more and apply to the grant program through the simple application process below. All applications must be submitted by December 15th. Winners will be announced December 27th. There will be an informational webinar about the grant held on December 7th, more details to come.

Eligible organizations should complete the Grant Program application by 7PM, ET (GMT -5) on December 15th, 2017.

Application deadline:
7PM ET (GMT -5) on December 15th, 2017

Award amount:
Grant recipients will receive:

  • (up to) 500 OraQuick In-Home HIV testing kits
  • (up to) 200 OraQuick ADVANCE HIV 1/2 Antibody tests
  • (up to) $5,000 (USD) to assist with the costs of supporting an HIV testing program


Winners announced:
December 27 2017

 

Summary

Since its 2012 launch, The OraQuick In-Home HIV Test has become a dependable tool in the fight against HIV/AIDS.

  • Used by over 1 million consumers.
  • Same device used by health care professionals.
  • 24 hour bilingual customer phone support and detailed product website.

OraSure continues to invest significantly in creating new methods of test distribution and driving awareness of this testing option.

Pilot Projects

Projects have taken place in New York City, Virginia, and Arizona and have documented some positive outcomes including:

  • 43% Of the participants report have never been tested or last tested over a year ago.
  • .8 - 1% Seropositive rate
  • Excellent Cascade of Care results. 80% linked to care. 75% of those linked on ART.
  • 89% of the participants rate the product as very easy to use.
  • Easy to Execute - ~2500 redemption codes were distributed in just 23 days.
  • 86% of participants in one project reported a high risk of HIV exposure.
  • Reaches young participants. In one project the majority of the participants were under the age of 35.

Distribution Methods

Grant recipients will choose which distribution method(s) is/are best suited for their program.

  • Direct - OraQuick In-Home HIV Test distributed by public health agencies.
  • Online - OraQuick In-Home HIV Test is ordered by the patient using a redemption code and is delievered via U.S. Post Office from the OraQuick.Com website.
  • Retail Access Card - The OraQuick In-Home HIV Test is picked up by patients free of charge at any Walgreens or Duane Reade location using a single-use Retail Access Card.

Program Rules

  • The work described in the application must include use of the OraQuick In-Home HIV Test.
  • Applicants who have a relative or member of their household currently employed by OraSure Technologies are ineligible to enter.
  • Applicant is responsible for ensuring that all necessary and legally required informed con-sents, authorizations, approvals, and permission have been obtained in order to participate in this program including any required Internal Review Board (IRB) approvals.
  • Applicant agrees that the project will be fully operational within 6 months of the date of the award being received.
  • Institutional overhead costs are restricted to a maximum of 5% of the funds awarded as part of this program.
  • Applicants must allow OraSure to publicly announce their name, project name or area of re-search, and institution or organization if they are selected as a winner.
  • OraSure will keep all abstracts, applicant names and institutions, and all information sub-mitted in the program applications process confidential, except in the case of the winners.
  • All decisions of the selection committee are final. The selection process is confidential except for the grant recipient details.
  • The winner agrees to provide ongoing progress report on the project after the receipt of the award.
  • The winner agrees that within 30 days of the completion date of the project, they will submit a written financial report outlining the use of award funds as well as a written report on all findings, data, results, and information garnered as a result of the project.
  • All data from the program must be shared with OraSure, to the extent such information is not subject to patient confidentiality restrictions.
  • Applications will only be accepted for consideration when received via online application form. All other applications will be rejected and destroyed. Under no circumstances will any materials be returned.
  • Applicants agree to comply with the additional OraQuick HIV Testing Grant Program terms and conditions.
  • Prior purchases of the OraQuick HIV Test Kits are not considered in any way during the selection process.
  • The AIDs Institute will review the proposals and select the winners without participation by OraSure, subject to OraSure's right to refuse to make an award if OraSure concludes such award would violate the law.

Eligibility

Funding for the OraQuick HIV Testing Grant is available to eligible public health entities that are looking to enhance their existing HIV testing programs. Eligible organizations include:

  • Nonprofits - Eligible applicants include: Nonprofits with 501(c)(3) IRS Status and Nonprofits without 501(c)(3) IRS status.
  • Health Departments - Eligible applicants include state, local and territorial health departments.
  • Governments - Eligible applicants include: State, County, City, Township; Special District Governments - Indian/Native American Tribal Governments (Federally recognized), Indian/Native American Tribal Governments (Other than Federally recognized); Eligible agencies of the Federal Government, U.S. Territories or Possessions.
  • Higher Education Institutions - Public/State controlled institutions of higher education or private institutions of higher education.
  • Other - Independent School Districs, Public Housing Authorities, Faith-Based or Community-Based organizations or regional organizations.

Applications must be submitted before December 15, 2017 at 7:00pm EST

Apply